Promising Canadian Stroke Drug Receives Large Research Grant
September 15, 2014
(The Globe and Mail) – A Phase III trial involving a promising stroke drug will receive a $6.6-million injection from Brain Canada – yet another endorsement for a Canadian medication that takes aim at the country’s third leading cause of death. A Phase III trial involving a promising stroke drug will receive a $6.6-million injection from Brain Canada – yet another endorsement for a Canadian medication that takes aim at the country’s third leading cause of death.